论文部分内容阅读
输血是临床各科,尤其是对血液病患者的一种重要辅助治疗手段。输血后肝炎(PTH)仍然是输血后主要并发症之一。为防止输血后肝炎的发生,乙型肝炎表面抗原(HBsAg)已作为规定的献血者常规筛检项目。检测方法已由最简便的快速反向血凝试验(RPHA)改为酶免疫法(EIA)。
Blood transfusion is an important adjuvant therapy for clinical subjects, especially for patients with blood diseases. Posttransfusion hepatitis (PTH) remains one of the major complications after transfusion. To prevent the occurrence of post-transfusion hepatitis, hepatitis B surface antigen (HBsAg) has been used as a routine blood donor screening program. The test method has been changed from the simplest rapid reverse hemagglutination test (RPHA) to enzyme immunoassay (EIA).